microdosing glp 1 benefits GLP-1 for weight loss vs. GLP-1 🤍 👉They serve different purposes, and the right approach depends entirely on YOU. They key is knowing: ✨What your body needs. ✨ What your goals Microdosing GLP-1s: Safety, Dosage, Side

Clinical considerations for specific populations: Individuals with diabetes should consult their GP or diabetes specialist before making significant dietary changes, as alterations in carbohydrate intake and meal timing may affect blood glucose control and medication requirements Those taking insulin or sulfonylureas should be particularly cautious, as dietary changes may increase the risk of hypoglycaemia [15] [16] Those with kidney disease should seek medical advice before substantially increasing protein intake People with digestive disorders (such as irritable bowel syndrome) may need to modify fibre recommendations based on individual tolerance Seek urgent medical attention for severe abdominal pain (especially if radiating to the back), persistent vomiting, blood in stool, or symptoms of hypoglycaemia or hyperglycaemia

some randomized controlled trials demonstrated that liraglutide, dulaglutide, semaglutide, and albiglutide reduced the rate of CV events in T2DM patients ( Another novel glucose-lowering agent is tirzepatide which has a dual mechanism of action: a GLP-1 and a glucose-dependent insulinotropic polypeptide (GIP) co-agonist

The first major commercial success from this development was semaglutide , marketed by Novo Nordisk as Ozempic for type 2 diabetes and Wegovy for obesity

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4)

There are warranted concerns about whether bad actors within the compounding industry have put out inferior or unsafe products, and the industry certainly deserves careful scrutiny